India to Sri Lanka: Immunoglobulin Export Trade Route

The India to Sri Lanka Immunoglobulin corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $27.9M USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's immunoglobulin manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $606.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with immunoglobulin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 13.8%, placing it at rank #13 among India's top immunoglobulin export destinations globally.

On the import side, key buyers of Indian immunoglobulin in Sri Lanka include STATE PHARMACEUTICALS CORPORATION , STATE PHARMACEUTICALS CORPORATION O, STATE PHARMACEUTICALS CORPORATION and 15 others. STATE PHARMACEUTICALS CORPORATION is the single largest importer with 9 shipments valued at $8.4M USD.

India's immunoglobulin exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED , RELIANCE LIFE SCIENCES PVT LTD — together account for 92% of total trade value on this route. The average shipment value of $606.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as 8000 vials human normal immunoglobulin for intravenous administration bp 5% solution immunorel 5%immunorel 5 pct 100 m and 25000 vials of human normal immunoglobulin for intravenous use bp 5 percent immunorel ( immunorel 5 pct 100ml), suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE PHARMACEUTICALS CORPORATION is the largest importer with 9 shipments worth $8.4M USD — representing 30% of all immunoglobulin imports from India on this route. A total of 18 buyers are active on this corridor.